Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA) to ...

Pathology labs facing high volumes and regulatory pressures can achieve 40-60% reductions in manual errors and 25-35% faster turnaround times through LIMS integration that automates sample tracking ...

Four pathology laboratories in the US have adopted PathAI’s enterprise workflow solution, AISight Image Management System (IMS), to improve their digital operations. The laboratories are Annapath ...

US-based Mopec has announced an expansion of its partnership with digital pathology technology provider Lumea. The expanded alliance will see Mopec incorporate Lumea's patented tissue-handling ...

- Results showed 100% sensitivity and reduced time to diagnosis by an estimated 65.5%, with potential to improve pathologists’ workflow in a real-world environment -Brazil-based Grupo Oncoclinicas is ...

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a software company that develops AI-powered pathology software, has launched its first product that assists digital pathology labs across research, ...

Digital pathology is increasingly recognized as the future of diagnostic and research workflows, providing greater clarity and deeper insights than traditional microscope-based approaches. Looking ...

Digital pathology (DP) is transitioning from an adjunct technology to an enterprise diagnostic platform in the United States.

TUCSON, Ariz., Oct. 27, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today a first-of-its-kind integration of the VIRTUOSO digital pathology ...

Voicebrook integration into Lumea’s pathology software enables practical, voice-enabled workflows across the modern pathology lab, from grossing to diagnosis. LEHI ...